Technologies Market
Research Report By Transfection Method (Cotransfection,
Electroporation, Cationic Lipid Transfection, In Vivo Transfection), By
Applications (Virus production, Protein production, Gene silencing, Stem cell
reprogramming & differentiation, Stable cell line generation), Geography
(North America, South America, Europe, Asia-Pacific, Middle East and Africa) –
Industry Trends and Forecast to 2026

of the major market competitors currently working in the global Transfection
technologies market are Lonza., Promega Corporation., Sigma-Aldrich Co. ,
Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc. , Roche Molecular
Systems, Inc., QIAGEN, Inovio Pharmaceuticals, Inc., POLYPLUS TRANSFECTION,
Mirus Bio LLC, Takara Bio Inc., SignaGen Laboratories, MaxCyte, Inc., Genlantis
Inc., Techulon, BioAstrum Corporation., Altogen Biosystems, OZ Biosciences,
Boca Scientific, Inc., Biontex Laboratories GmbH. , and others.

Get Sample Copy
of Research Report @

transfection technologies market is registering a substantial CAGR of 9.74% in
the forecast period of 2019-2026. This rise in the market can be attributed to
surge in research & development in the field of cell based therapies and
massive funds by government and private players.

Market Definition: 

is an approach to produce exogenous nucleic acids such as DNA, RNA or
oligonucleotide into cells. Such nucleic acids can be transferred by polymeric
or lipid transfection reagents which promote the cellular absorption. This
method is widely used for genomic studies (cell representation, testing, RNA
interference, in vitro research) but can be conducted for bio-production
(vaccine and protein manufacturing) or medicinal reasons (animal cell
treatment). Nucleic acid delivery to cells can be accomplished by distinct
physical techniques, such as electroporation, sonoporation or microinjection;
however, these procedures are comparatively hazardous to cells. Transfection
with chemical substances is a better option for maintaining healthy cell

Market Drivers

  • Surge in research
    & development in the field of cell based therapies is contributing to the
    growth of the market
  • Massive funds by
    government and private players is boosting the growth of the market
  • Growing occurrences of
    cancer diseases is propelling the growth of the market
  • Increasing number of
    obese and overweight population is driving the growth of the market

Market Restraints

  • Cost of transfection
    technology instruments is hampering the growth of the market
  • Hazard of negative
    reaction with the cell is hindering the growth of the market
  • Home brew reagents
    restricts sale of business supply which is restricting the growth of the market

View Full TOC @


By Transfection Method

  •  Cotransfection
  •  Electroporation
  •  Cationic Lipid
  •  In Vivo

 By Applications

  •  Virus Production
  •  Protein
  •  Gene Silencing
  •  Stem Cell
    Reprogramming & Differentiation
  •  Stable Cell Line

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa
    • Rest of Middle East & Africa

Key Developments in the Market:

  • In December 2018,
    Polyplus-transfection SA declared the release of PEIpro-GMP, a transfection
    reagent for medical and industrial lentivirus and adeno-associated disease
    (AAV) tissue & DNA therapy. This reagent was launched to promote the
    medical stage and the commercialization stage of manufacturing.
  • In May 2018, Altogen
    Biosystems released a new version of AltoFect, a second generation transfection
    reagent for the hard-to-transfect cell lines to primary cell types. AltoFect
    transfection reagent appears to have up to 85 percent efficiency of
    transfection in difficult-to-transfect cells, like B-cells, T-cells and primary
    cell cultures. This reagent allows scientists to solve difficulties and
    constraints linked to primary cells and difficult-to-transfect cell lines.

Competitive Analysis:

Transfection technologies market is highly fragmented and the major players
have used various strategies such as new product launches, expansions,
agreements, joint ventures, partnerships, acquisitions, and others to increase
their footprints in this market. The report includes market shares of
Transfection technologies market for global, Europe, North America,
Asia-Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

  • Current and future of
    global transfection technologies market outlook in the developed and emerging
  • The segment that is
    expected to dominate the market as well as the segment which holds highest CAGR
    in the forecast period
  • Regions/Countries that
    are expected to witness the fastest growth rates during the forecast period
  • The latest
    developments, market shares, and strategies that are employed by the major
    market players

Customization of the Report:

  • All segmentation
    provided above in this report is represented at country level
  • All products covered
    in the market, product volume and average selling prices will be included as
    customizable options which may incur no or minimal additional cost (depends on

Enquire for further
detailed information before the purchase of this research report @

About Data Bridge Market Research

An absolute way to forecast what future holds is
to comprehend the trend today!

Data Bridge set forth itself as an unconventional
and neoteric Market research and consulting firm with an unparalleled level of
resilience and integrated approaches. We are determined to unearth the best
market opportunities and foster efficient information for your business to
thrive in the market. Data Bridge endeavors to provide appropriate solutions to
complex business challenges and initiates an effortless decision-making
process. Data Bridge is an aftermath of sheer wisdom and experience which was
formulated and framed in the year 2015 in Pune.


Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475 

Email: [email protected]

Source link